back
SEDI Insider filing browser
| Date | Issuer | Insider | Transaction | Amount | New Balance ⓘ
The balance of securities held by registered holder at the time of the transaction. Insiders may direct multiple registered holders and hold multiple security types.
|
|
|---|---|---|---|---|---|---|
| Filed 2023-12-26 11:18 Tx date 2023-12-23 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$14,800
+40,000 vol $0.37 each |
48,000 | |
| Filed 2022-12-19 13:07 Tx date 2022-12-16 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$7,476
+4,200 vol $1.78 each |
8,000 | |
| Filed 2022-11-17 15:18 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
||
| Filed 2022-11-15 18:08 Tx date 2022-11-14 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
50 - Grant of options
|
$11,676
+4,200 vol $2.78 each |
8,000 | |
| Filed 2022-10-26 13:20 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,412 vol |
12,183 | |
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,411 vol |
||
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
37 - Stock split or consolidation
|
-292,411 vol |
12,184 | |
| Filed 2022-10-12 18:13 Tx date 2022-09-07 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
37 - Stock split or consolidation
|
-91,200 vol |
3,800 | |
| Filed 2022-01-06 18:19 Tx date 2022-01-06 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,710
+8,500 vol $1.26 each |
304,595 | |
| Filed 2021-12-30 21:15 Tx date 2021-12-30 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$10,736
+8,093 vol $1.33 each |
296,095 | |
| Filed 2021-11-15 13:31 Tx date 2021-11-15 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
10 - Acquisition or disposition in the public market
|
$6,845
+5,000 vol $1.37 each |
288,002 | |
| Filed 2021-11-02 18:22 Tx date 2021-11-02 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Common Shares
00 - Opening Balance-Initial SEDI Report
|
283,002 | ||
| Filed 2021-11-02 18:17 Tx date 2021-11-02 |
$INM
InMed Pharmaceuticals Inc. |
Johnson, Shane Aaron
5 - Senior Officer of Issuer
Direct Ownership
|
Options
00 - Opening Balance-Initial SEDI Report
|
95,000 |